David Jones

2.5k total citations · 1 hit paper
34 papers, 1.7k citations indexed

About

David Jones is a scholar working on Pathology and Forensic Medicine, Mechanics of Materials and Analytical Chemistry. According to data from OpenAlex, David Jones has authored 34 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 6 papers in Mechanics of Materials and 6 papers in Analytical Chemistry. Recurrent topics in David Jones's work include Multiple Sclerosis Research Studies (12 papers), Hydrocarbon exploration and reservoir analysis (6 papers) and Petroleum Processing and Analysis (6 papers). David Jones is often cited by papers focused on Multiple Sclerosis Research Studies (12 papers), Hydrocarbon exploration and reservoir analysis (6 papers) and Petroleum Processing and Analysis (6 papers). David Jones collaborates with scholars based in United States, United Kingdom and Canada. David Jones's co-authors include Charles E. West, Alan G. Scarlett, Steven J. Rowland, Richard Frank, June Halper, Gabriel Pardo, Myla Goldman, L. Mark Hewitt, John A. Kirby and Andrea Broad and has published in prestigious journals such as Nature, Environmental Science & Technology and Hepatology.

In The Last Decade

David Jones

31 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis

2018 395 citations Alexander Rae‐Grant, Gregory S. Day et al. Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Jones United States	18	896	346	300	268	215	34	1.7k
Kenichi Hashimoto Japan	18	68 0.1×	14 0.0×	26 0.1×	99 0.4×	24 0.1×	128	1.1k
Takeshi Yamada Japan	26	282 0.3×	18 0.1×	4 0.0×	118 0.4×	991 4.6×	247	2.5k
Xiangyan Ruan China	26	272 0.3×	2 0.0×	73 0.2×	11 0.0×	219 1.0×	154	2.1k
Olav A. Haugen Norway	24	156 0.2×	24 0.1×	6 0.0×	43 0.2×	392 1.8×	64	1.9k
John H. Bland United States	26	245 0.3×	8 0.0×	7 0.0×	59 0.2×	70 0.3×	59	1.8k
Bao Liu China	24	67 0.1×	3 0.0×	12 0.0×	151 0.6×	159 0.7×	207	1.9k
Frederick W.K. Tam United Kingdom	34	259 0.3×	28 0.1×	2 0.0×	30 0.1×	152 0.7×	90	3.4k
Lei Wu China	17	64 0.1×	17 0.0×	7 0.0×	33 0.1×	267 1.2×	71	1.2k
Shengshou Hu China	18	93 0.1×	4 0.0×	14 0.0×	33 0.1×	90 0.4×	62	1.7k

Countries citing papers authored by David Jones

Since Specialization

Citations

This map shows the geographic impact of David Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Jones more than expected).

Fields of papers citing papers by David Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Jones. The network helps show where David Jones may publish in the future.

Co-authorship network of co-authors of David Jones

This figure shows the co-authorship network connecting the top 25 collaborators of David Jones. A scholar is included among the top collaborators of David Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Jones. David Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cobb, Bryan, Richard J. Karpowicz, David Jones, et al.. (2024). Clinical Applications of Digital Biomarkers in Multiple Sclerosis: A Systematic Literature Review (P5-6.013). Neurology. 102(7_supplement_1).

Rae‐Grant, Alexander, Gregory S. Day, Ruth Ann Marrie, et al.. (2018). Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology. 90(17). 777–788. 395 indexed citations breakdown →

Rae‐Grant, Alexander, Gregory S. Day, Ruth Ann Marrie, et al.. (2018). Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology. 90(17). 789–800. 105 indexed citations

Martin, Allison N., et al.. (2017). Anti‐Yo Mediated Paraneoplastic Cerebellar Degeneration Associated with Pseudobulbar Affect in a Patient with Breast Cancer. Case Reports in Oncological Medicine. 2017(1). 8120689–8120689. 5 indexed citations

Pardo, Gabriel & David Jones. (2017). The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. Journal of Neurology. 264(12). 2351–2374. 74 indexed citations

Tintoré, Mar, Kathleen Costello, Martin Duddy, et al.. (2016). The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction. Patient Preference and Adherence. Volume 11. 33–45. 61 indexed citations

Jones, David, et al.. (2016). Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis. Multiple Sclerosis and Related Disorders. 9. 47–49. 30 indexed citations

Newsome, Scott D., Philip J. Aliotta, Jacquelyn Bainbridge, et al.. (2016). A Framework of Care in Multiple Sclerosis, Part 1. International Journal of MS Care. 18(6). 314–323. 12 indexed citations

Traboulsee, Anthony, Jack H. Simon, L. Stone, et al.. (2015). Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis. American Journal of Neuroradiology. 37(3). 394–401. 243 indexed citations

10.

Wilde, Michael, Charles E. West, Alan G. Scarlett, et al.. (2014). Bicyclic naphthenic acids in oil sands process water: Identification by comprehensive multidimensional gas chromatography–mass spectrometry. Journal of Chromatography A. 1378. 74–87. 43 indexed citations

11.

Jones, David & Myla Goldman. (2014). Alemtuzumab for the treatment of relapsing-remitting multiple sclerosis: a review of its clinical pharmacology, efficacy and safety. Expert Review of Clinical Immunology. 10(10). 1281–1291. 10 indexed citations

12.

Jones, David, et al.. (2014). Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis. Expert Opinion on Drug Safety. 13(7). 989–998. 36 indexed citations

13.

Ding, Dale, Michelle Fullard, Heather Jarrell, & David Jones. (2013). Intramedullary spinal cord metastasis from salivary ductal carcinoma of the parotid gland mimicking transverse myelitis in a patient with radiologically isolated syndrome. Journal of the Neurological Sciences. 336(1-2). 265–268. 5 indexed citations

14.

Jones, David, Alan G. Scarlett, Charles E. West, et al.. (2013). Elemental and spectroscopic characterization of fractions of an acidic extract of oil sands process water. Chemosphere. 93(9). 1655–1664. 21 indexed citations

15.

Jones, David, Charles E. West, Alan G. Scarlett, Richard Frank, & Steven J. Rowland. (2012). Isolation and estimation of the ‘aromatic’ naphthenic acid content of an oil sands process-affected water extract. Journal of Chromatography A. 1247. 171–175. 84 indexed citations

16.

Rowland, Steven J., et al.. (2012). Differentiation of two industrial oil sands process‐affected waters by two‐dimensional gas chromatography/mass spectrometry of diamondoid acid profiles. Rapid Communications in Mass Spectrometry. 26(5). 572–576. 39 indexed citations

17.

Broad, Andrea, David Jones, & John A. Kirby. (2006). Toll-Like Receptor (TLR) Response Tolerance: A Key Physiological “ Damage Limitation ” Effect and an Important Potential Opportunity for Therapy. Current Medicinal Chemistry. 13(21). 2487–2502. 82 indexed citations

18.

Stewart, Stephen, Matteo Vidali, Christopher P. Day, Emanuele Albano, & David Jones. (2004). Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease. Hepatology. 39(1). 197–203. 71 indexed citations

19.

Jones, David, et al.. (1990). The analysis of smokestack samples for dioxins by gas chromatography/mass spectrometry and gas chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 4(10). 418–420.

20.

Jones, David, et al.. (1982). The fluorometric determination of 3‐methylhistidine in meat and meat products. Journal of the Science of Food and Agriculture. 33(7). 677–685. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact